India Won't Cease Controversial Drug-Licensing Policy
The Indian government on Tuesday firmly denied reports that it will stop issuing compulsory licenses that enable generic drug companies to make affordable versions of name-brand medicines without the permission of...To view the full article, register now.
Already a subscriber? Click here to view full article